Owner BioRexis Technology, Inc

Inventors Prior, Christopher P.; Sadeghi, Homayoun; Turner, Andrew

Agent Allens Arthur Robinson

Pub. Number AU-B-2003272241

PCT Number PCT/US03/26744

PCT Pub. Number WO2004/020404

Priority 10/384,060 10.03.03 US; 60/406,977 30.08.02 US

Filing date 28 August 2003

Wipo publication date 19 March 2004

Acceptance publication date 27 May 2010

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A01K 67/00 (2006.01) Rearing or breeding animals, not otherwise provided for

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/79 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/65 (2006.01) Mutation or genetic engineering - using markers

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors